CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,121 | -43.3% | 63,660 | -24.5% | 0.00% | – |
| Q2 2023 | $144,955 | -36.6% | 84,276 | -44.3% | 0.00% | – |
| Q1 2023 | $228,577 | +695.9% | 151,375 | +743.4% | 0.00% | – |
| Q4 2022 | $28,718 | +30.5% | 17,949 | +19.2% | 0.00% | – |
| Q3 2022 | $22,000 | -92.5% | 15,053 | -90.7% | 0.00% | – |
| Q2 2022 | $295,000 | +43.2% | 161,421 | +107.9% | 0.00% | – |
| Q1 2022 | $206,000 | -45.2% | 77,654 | -11.0% | 0.00% | – |
| Q4 2021 | $376,000 | -37.4% | 87,243 | -26.2% | 0.00% | – |
| Q3 2021 | $601,000 | -85.1% | 118,232 | -81.4% | 0.00% | -100.0% |
| Q2 2021 | $4,027,000 | +4751.8% | 636,037 | +5827.7% | 0.00% | – |
| Q1 2021 | $83,000 | -95.8% | 10,730 | -96.4% | 0.00% | – |
| Q4 2020 | $1,976,000 | +3700.0% | 301,639 | +3761.7% | 0.00% | – |
| Q3 2020 | $52,000 | -75.9% | 7,811 | -69.9% | 0.00% | – |
| Q2 2020 | $216,000 | +4.9% | 25,929 | -3.6% | 0.00% | – |
| Q1 2020 | $206,000 | -63.0% | 26,885 | -59.9% | 0.00% | – |
| Q4 2019 | $557,000 | +197.9% | 67,107 | +165.7% | 0.00% | – |
| Q3 2019 | $187,000 | -95.0% | 25,261 | -92.4% | 0.00% | -100.0% |
| Q2 2019 | $3,715,000 | +201.1% | 331,094 | +188.5% | 0.00% | – |
| Q1 2019 | $1,234,000 | -3.2% | 114,764 | +36.0% | 0.00% | – |
| Q4 2018 | $1,275,000 | -28.3% | 84,379 | -12.2% | 0.00% | – |
| Q3 2018 | $1,778,000 | -29.8% | 96,082 | -13.3% | 0.00% | -100.0% |
| Q2 2018 | $2,534,000 | -33.7% | 110,844 | -17.5% | 0.00% | 0.0% |
| Q1 2018 | $3,824,000 | +82.0% | 134,407 | +35.0% | 0.00% | 0.0% |
| Q4 2017 | $2,101,000 | -40.9% | 99,531 | -49.2% | 0.00% | 0.0% |
| Q3 2017 | $3,558,000 | +212.9% | 195,869 | +167.0% | 0.00% | – |
| Q2 2017 | $1,137,000 | -37.9% | 73,350 | -30.9% | 0.00% | – |
| Q1 2017 | $1,832,000 | +30.7% | 106,168 | -16.8% | 0.00% | – |
| Q4 2016 | $1,402,000 | +1769.3% | 127,552 | +2593.8% | 0.00% | – |
| Q3 2016 | $75,000 | +525.0% | 4,735 | +307.8% | 0.00% | – |
| Q2 2016 | $12,000 | -7.7% | 1,161 | +16.1% | 0.00% | – |
| Q1 2016 | $13,000 | -89.4% | 1,000 | -83.1% | 0.00% | – |
| Q4 2015 | $123,000 | – | 5,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |